Compare Danaher Corporation (DHR) vs Ecolab Inc. (ECL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Ecolab Inc. — how do they compare? Danaher Corporation trades at $219.8 (market cap $152.87B), while Ecolab Inc. trades at $281.42 (market cap $78.97B). The key difference: Danaher Corporation is the larger of the two by market cap, and Ecolab Inc. pays the higher dividend (1.04%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Ecolab Inc. for 90 Days on average.
| DHR | ECL | |
|---|---|---|
Market Cap | $152.87B | $78.97B |
Volume | 5,228,698 | 974,947 |
Sector | Health | Basic Materials |
52-Week High | $242.05 | $308.35 |
52-Week Low | $161.91 | $245.73 |
Typical Hold Time | 69 Days | 90 Days |
Enterprise Value | $175.08B | $87.75B |
Dividend Yield | 0.74% | 1.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
ECL trades at $281.83, up 1.34% today, with strong analyst support (78% buy ratings) and a $326.38 consensus price target. The stock shows bullish technical momentum above key support at $279, while fundamentals reveal steady revenue growth to $16.08B in 2025 and robust profitability with 12.57% net margins. Recent Q2 earnings beat expectations, and the company maintains dividend aristocrat status with consistent payout increases.
Outlook remains positive given ECL's essential service contracts, digital segment growth, and high institutional ownership. Key risks include rising debt from the $4.75B CoolIT acquisition and cost inflation pressures. The stock offers a compelling growth-and-income profile for investors seeking exposure to defensive industrial services with recurring revenue streams.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →
